Biomarkers of Necrotizing Enterocolitis: The Search Continues

Clin Perinatol. 2022 Mar;49(1):181-194. doi: 10.1016/j.clp.2021.11.011. Epub 2022 Jan 21.

Abstract

Necrotizing enterocolitis (NEC) is the most common gastrointestinal (GI) emergency in the neonatal intensive care unit. Despite advances in medical care, mortality and morbidity from NEC have not changed. This is likely due to the lack of a clear understanding of this multifactorial disease, and reliable biomarkers for accurate diagnosis of NEC. Currently, the diagnosis of NEC is made by a combination of nonspecific clinical signs, symptoms, and radiological findings. Though biomarkers have been studied extensively, none offer an acceptable sensitivity or specificity to be used. This review will focus on the available literature on biomarkers for preterm NEC, acknowledging the limitations in studies including the variability of inclusion criteria, and most importantly, the lack of gold standard case definition for NEC.

Keywords: Biomarkers; Metabolomics; Necrotizing enterocolitis; Proteomics; Transcriptomics.

Publication types

  • Review

MeSH terms

  • Biomarkers
  • Enterocolitis, Necrotizing* / diagnosis
  • Female
  • Fetal Diseases*
  • Humans
  • Infant, Newborn
  • Infant, Newborn, Diseases*
  • Infant, Premature

Substances

  • Biomarkers